Beijing Leadman Biochemistry (300289.SZ) released its performance for the first three quarters, with a net income of 1.0716 million yuan, a year-on-year decrease of 95.49%.

Zhitong Finance · Oct 25 16:28

Beijing Leadman Biochemistry (300289.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters reaching 2.8...

Zhithong Finance APP News, Beijing Leadman Biochemistry (300289.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters at 0.282 billion yuan, a 17.15% year-on-year decrease; net income attributable to shareholders of the listed company was 1.0716 million yuan, a 95.49% year-on-year decrease; net loss excluding non-recurring gains and losses attributable to shareholders of the listed company was 6.5087 million yuan; basic earnings per share was 0.002 yuan/share.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

利德曼(300289.SZ)发布前三季度业绩，净利润107.16万元，同比下降95.49%

Beijing Leadman Biochemistry (300289.SZ) released its performance for the first three quarters, with a net income of 1.0716 million yuan, a year-on-year decrease of 95.49%.

Risk Disclaimer

Statement